Share Price and Basic Stock Data
Last Updated: December 11, 2025, 9:48 pm
| PEG Ratio | 0.25 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Tainwala Chemicals & Plastics (India) Ltd operates in the plastics sector, focusing primarily on sheets and films. As of the latest reporting period, the company’s stock price stood at ₹170, and its market capitalization was ₹159 Cr. Revenue trends indicate a significant recovery in recent quarters, with sales rising from ₹1.77 Cr in June 2022 to ₹8.14 Cr in March 2023. However, this was followed by a modest decline to ₹6.48 Cr in June 2023 and ₹6.36 Cr in September 2023. Such fluctuations suggest that while the company has managed to rebound from previous lows, its revenue generation remains inconsistent, reflecting potential volatility in demand or operational efficiency. Over the fiscal year ending March 2024, Tainwala reported sales of ₹18.03 Cr, which signifies a commendable growth trajectory from ₹12.83 Cr in March 2023, showcasing the company’s ability to adapt and grow in a competitive market.
Profitability and Efficiency Metrics
Profitability metrics reveal a mixed picture for Tainwala Chemicals. The company recorded a net profit of ₹6.94 Cr for the trailing twelve months, translating to an earnings per share (EPS) of ₹7.41. However, the operating profit margin (OPM) remains negative at -3.96%, highlighting ongoing challenges in controlling costs or achieving operational efficiency. The reported operating profit for the fiscal year ending March 2025 was ₹1.27 Cr, marking a turnaround from a negative operating profit of ₹5.43 Cr in the previous year. Notably, the interest coverage ratio stood at an impressive 54.94x, indicating that the company is well-positioned to meet its financial obligations without the burden of debt, as it has reported zero borrowings. The cash conversion cycle of 64.09 days reflects a relatively efficient working capital management, although the company must ensure it converts sales into cash more effectively to enhance liquidity.
Balance Sheet Strength and Financial Ratios
The balance sheet of Tainwala Chemicals appears robust, with total reserves reported at ₹162.66 Cr and no outstanding borrowings, which is a significant strength in today’s economic climate. The company’s price-to-book value (P/BV) ratio of 0.40x suggests that the stock may be undervalued relative to its net assets, offering an attractive entry point for potential investors. The return on equity (ROE) is relatively low at 3.31%, indicating that while the company has substantial equity, it is not generating high returns for shareholders. Conversely, the return on capital employed (ROCE) of 4.24% signals that Tainwala is starting to utilize its capital more effectively, especially as it transitions out of a phase of negative operational results. Overall, the financial ratios indicate a cautious optimism, but the company must leverage its asset base more efficiently to enhance shareholder value.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Tainwala Chemicals shows a strong promoter holding of 67.45%, which can be seen as a vote of confidence in the company’s future prospects. Institutional ownership is minimal, with foreign institutional investors (FIIs) holding just 0.05% and domestic institutional investors (DIIs) at 0.22%. This low institutional interest might reflect a cautious stance towards the company’s operational challenges and profitability issues. The public shareholding stands at 32.27%, with the number of shareholders increasing to 8,335, indicating growing retail interest. This can be viewed positively, as it suggests that retail investors are beginning to recognize the potential upside in Tainwala’s recovery story. However, the lack of significant institutional backing could pose risks if the company faces any headwinds, as institutional investors often provide stability and confidence in turbulent times.
Outlook, Risks, and Final Insight
Looking ahead, Tainwala Chemicals faces a mixed outlook. On one hand, the consistent increase in sales and the turnaround in profitability metrics could bode well for future growth. However, the company must navigate significant risks, including the volatile nature of raw material prices and the overall demand in the plastics sector, which remains sensitive to economic cycles. The negative operating profit margin is a critical area that needs attention; improving operational efficiency will be key to unlocking greater profitability. Furthermore, the low institutional investor interest could be a double-edged sword, as it may lead to increased volatility in the stock price. For potential investors, the current valuation might present an opportunity, but it is essential to weigh these risks carefully. Understanding the broader market dynamics and Tainwala’s execution capabilities will be crucial in assessing whether to take a position in this stock.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Tainwala Chemicals & Plastics (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Adhesives Ltd | 154 Cr. | 300 | 442/281 | 8.47 | 200 | 0.00 % | 17.2 % | 18.0 % | 10.0 |
| G M Polyplast Ltd | 88.8 Cr. | 66.0 | 156/65.0 | 12.1 | 31.7 | 0.00 % | 28.8 % | 21.0 % | 10.0 |
| Duropack Ltd | 33.8 Cr. | 64.0 | 122/63.0 | 20.6 | 41.1 | 0.00 % | 10.3 % | 8.09 % | 10.0 |
| Command Polymers Ltd | 26.6 Cr. | 28.3 | 46.3/28.2 | 47.4 | 13.2 | 0.00 % | 4.73 % | 3.64 % | 10.0 |
| Bansal Roofing Products Ltd | 143 Cr. | 109 | 135/81.0 | 18.8 | 26.8 | 0.92 % | 22.4 % | 18.2 % | 10.0 |
| Industry Average | 544.83 Cr | 98.81 | 19.39 | 70.82 | 0.36% | 14.04% | 11.51% | 7.70 |
All Competitor Stocks of Tainwala Chemicals & Plastics (India) Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.77 | 1.18 | 1.74 | 8.14 | 6.48 | 6.36 | 4.40 | 0.79 | 1.55 | 4.97 | 4.59 | 5.31 | 1.01 |
| Expenses | 2.08 | 2.19 | 1.68 | 12.31 | 6.64 | 6.28 | 4.43 | 0.91 | 1.27 | 5.08 | 4.02 | 4.76 | 1.05 |
| Operating Profit | -0.31 | -1.01 | 0.06 | -4.17 | -0.16 | 0.08 | -0.03 | -0.12 | 0.28 | -0.11 | 0.57 | 0.55 | -0.04 |
| OPM % | -17.51% | -85.59% | 3.45% | -51.23% | -2.47% | 1.26% | -0.68% | -15.19% | 18.06% | -2.21% | 12.42% | 10.36% | -3.96% |
| Other Income | 0.55 | 3.83 | 3.57 | 1.82 | 0.55 | 5.38 | 0.51 | -0.24 | 0.79 | 3.77 | 0.57 | 0.26 | 3.09 |
| Interest | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Depreciation | 0.09 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.07 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 |
| Profit before tax | 0.15 | 2.70 | 3.51 | -2.48 | 0.26 | 5.34 | 0.37 | -0.43 | 0.97 | 3.56 | 1.03 | 0.72 | 2.96 |
| Tax % | 13.33% | 10.00% | 0.00% | 13.71% | 0.00% | 11.61% | 27.03% | 2.33% | 18.56% | 4.21% | 84.47% | 23.61% | 5.07% |
| Net Profit | 0.14 | 2.44 | 3.51 | -2.82 | 0.26 | 4.72 | 0.27 | -0.44 | 0.79 | 3.42 | 0.16 | 0.55 | 2.81 |
| EPS in Rs | 0.15 | 2.61 | 3.75 | -3.01 | 0.28 | 5.04 | 0.29 | -0.47 | 0.84 | 3.65 | 0.17 | 0.59 | 3.00 |
Last Updated: August 20, 2025, 2:45 am
Below is a detailed analysis of the quarterly data for Tainwala Chemicals & Plastics (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1.01 Cr.. The value appears to be declining and may need further review. It has decreased from 5.31 Cr. (Mar 2025) to 1.01 Cr., marking a decrease of 4.30 Cr..
- For Expenses, as of Jun 2025, the value is 1.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.76 Cr. (Mar 2025) to 1.05 Cr., marking a decrease of 3.71 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 0.55 Cr. (Mar 2025) to -0.04 Cr., marking a decrease of 0.59 Cr..
- For OPM %, as of Jun 2025, the value is -3.96%. The value appears to be declining and may need further review. It has decreased from 10.36% (Mar 2025) to -3.96%, marking a decrease of 14.32%.
- For Other Income, as of Jun 2025, the value is 3.09 Cr.. The value appears strong and on an upward trend. It has increased from 0.26 Cr. (Mar 2025) to 3.09 Cr., marking an increase of 2.83 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.09 Cr..
- For Profit before tax, as of Jun 2025, the value is 2.96 Cr.. The value appears strong and on an upward trend. It has increased from 0.72 Cr. (Mar 2025) to 2.96 Cr., marking an increase of 2.24 Cr..
- For Tax %, as of Jun 2025, the value is 5.07%. The value appears to be improving (decreasing) as expected. It has decreased from 23.61% (Mar 2025) to 5.07%, marking a decrease of 18.54%.
- For Net Profit, as of Jun 2025, the value is 2.81 Cr.. The value appears strong and on an upward trend. It has increased from 0.55 Cr. (Mar 2025) to 2.81 Cr., marking an increase of 2.26 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.00. The value appears strong and on an upward trend. It has increased from 0.59 (Mar 2025) to 3.00, marking an increase of 2.41.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:19 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.27 | 9.73 | 9.44 | 5.73 | 11.48 | 11.53 | 10.58 | 6.47 | 7.72 | 12.83 | 18.03 | 16.42 | 15.88 |
| Expenses | 8.91 | 10.73 | 11.85 | 8.11 | 14.37 | 14.93 | 12.56 | 8.90 | 11.43 | 18.26 | 19.12 | 15.15 | 14.91 |
| Operating Profit | -0.64 | -1.00 | -2.41 | -2.38 | -2.89 | -3.40 | -1.98 | -2.43 | -3.71 | -5.43 | -1.09 | 1.27 | 0.97 |
| OPM % | -7.74% | -10.28% | -25.53% | -41.54% | -25.17% | -29.49% | -18.71% | -37.56% | -48.06% | -42.32% | -6.05% | 7.73% | 6.11% |
| Other Income | 1.73 | 3.88 | 6.89 | 9.74 | 9.69 | 5.64 | 6.86 | 2.62 | 4.81 | 9.77 | 7.06 | 5.40 | 7.69 |
| Interest | 0.02 | 0.02 | 0.10 | 0.08 | 0.04 | 0.04 | 0.03 | 0.04 | 0.35 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.71 | 0.76 | 0.52 | 0.54 | 0.39 | 0.41 | 0.50 | 0.48 | 0.38 | 0.44 | 0.42 | 0.38 | 0.38 |
| Profit before tax | 0.36 | 2.10 | 3.86 | 6.74 | 6.37 | 1.79 | 4.35 | -0.33 | 0.37 | 3.89 | 5.54 | 6.28 | 8.27 |
| Tax % | 16.67% | 3.33% | 0.26% | 0.00% | 0.00% | -15.08% | 0.46% | 0.00% | 0.00% | 15.68% | 13.18% | 21.66% | |
| Net Profit | 0.30 | 2.03 | 3.86 | 6.74 | 6.37 | 2.05 | 4.34 | -0.32 | 0.37 | 3.28 | 4.81 | 4.92 | 6.94 |
| EPS in Rs | 0.32 | 2.17 | 4.12 | 7.20 | 6.80 | 2.19 | 4.63 | -0.34 | 0.40 | 3.50 | 5.14 | 5.25 | 7.41 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 576.67% | 90.15% | 74.61% | -5.49% | -67.82% | 111.71% | -107.37% | 215.62% | 786.49% | 46.65% | 2.29% |
| Change in YoY Net Profit Growth (%) | 0.00% | -486.52% | -15.54% | -80.10% | -62.33% | 179.53% | -219.08% | 323.00% | 570.86% | -739.84% | -44.36% |
Tainwala Chemicals & Plastics (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | 29% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 1% |
| 3 Years: | 50% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 35% |
| 3 Years: | 25% |
| 1 Year: | 3% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 1% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:04 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 | 9.36 |
| Reserves | 29.71 | 31.21 | 35.07 | 57.96 | 66.09 | 67.61 | 76.42 | 88.59 | 80.88 | 89.36 | 108.18 | 144.26 | 162.66 |
| Borrowings | 0.00 | 0.00 | 0.80 | 0.36 | 0.18 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 1.26 | 1.55 | 1.35 | 1.71 | 1.66 | 2.45 | 2.95 | 2.36 | 1.31 | 0.72 | 5.66 | 13.53 | 16.41 |
| Total Liabilities | 40.33 | 42.12 | 46.58 | 69.39 | 77.29 | 79.42 | 88.77 | 100.31 | 91.55 | 99.44 | 123.20 | 167.15 | 188.43 |
| Fixed Assets | 3.99 | 2.71 | 3.30 | 3.24 | 2.94 | 3.11 | 2.70 | 2.72 | 2.94 | 3.58 | 3.16 | 2.78 | 2.59 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 19.52 | 20.73 | 25.08 | 46.69 | 52.61 | 53.55 | 62.82 | 80.70 | 74.38 | 88.76 | 117.18 | 159.80 | 178.83 |
| Other Assets | 16.82 | 18.68 | 18.20 | 19.46 | 21.74 | 22.76 | 23.25 | 16.89 | 14.23 | 7.10 | 2.86 | 4.57 | 7.01 |
| Total Assets | 40.33 | 42.12 | 46.58 | 69.39 | 77.29 | 79.42 | 88.77 | 100.31 | 91.55 | 99.44 | 123.20 | 167.15 | 188.43 |
Below is a detailed analysis of the balance sheet data for Tainwala Chemicals & Plastics (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.36 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.36 Cr..
- For Reserves, as of Sep 2025, the value is 162.66 Cr.. The value appears strong and on an upward trend. It has increased from 144.26 Cr. (Mar 2025) to 162.66 Cr., marking an increase of 18.40 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 16.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.53 Cr. (Mar 2025) to 16.41 Cr., marking an increase of 2.88 Cr..
- For Total Liabilities, as of Sep 2025, the value is 188.43 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 167.15 Cr. (Mar 2025) to 188.43 Cr., marking an increase of 21.28 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2.59 Cr.. The value appears to be declining and may need further review. It has decreased from 2.78 Cr. (Mar 2025) to 2.59 Cr., marking a decrease of 0.19 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 178.83 Cr.. The value appears strong and on an upward trend. It has increased from 159.80 Cr. (Mar 2025) to 178.83 Cr., marking an increase of 19.03 Cr..
- For Other Assets, as of Sep 2025, the value is 7.01 Cr.. The value appears strong and on an upward trend. It has increased from 4.57 Cr. (Mar 2025) to 7.01 Cr., marking an increase of 2.44 Cr..
- For Total Assets, as of Sep 2025, the value is 188.43 Cr.. The value appears strong and on an upward trend. It has increased from 167.15 Cr. (Mar 2025) to 188.43 Cr., marking an increase of 21.28 Cr..
Notably, the Reserves (162.66 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.64 | -1.00 | -3.21 | -2.74 | -3.07 | -3.40 | -2.02 | -2.43 | -3.71 | -5.43 | -1.09 | 1.27 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 24.72 | 88.91 | 103.24 | 70.07 | 52.14 | 20.58 | 85.90 | 135.39 | 24.59 | 18.21 | 8.30 | 23.79 |
| Inventory Days | 261.55 | 139.70 | 168.06 | 394.27 | 167.16 | 208.52 | 179.74 | 280.66 | 239.23 | 73.92 | 33.16 | 42.57 |
| Days Payable | 11.71 | 27.28 | 19.41 | 72.35 | 32.09 | 55.65 | 83.09 | 97.47 | 18.80 | 4.60 | 2.30 | 2.27 |
| Cash Conversion Cycle | 274.56 | 201.32 | 251.89 | 391.99 | 187.21 | 173.44 | 182.56 | 318.59 | 245.01 | 87.53 | 39.16 | 64.09 |
| Working Capital Days | 185.37 | 174.81 | 271.82 | 348.44 | 211.43 | 218.11 | 176.98 | 306.89 | 189.12 | 93.31 | 41.70 | 57.13 |
| ROCE % | 0.39% | 3.94% | 8.28% | 11.16% | 8.49% | 1.77% | 5.25% | -1.26% | -3.17% | 2.74% | 4.24% | 4.24% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 14 | Mar 13 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.32 | 0.64 |
| Diluted EPS (Rs.) | 0.32 | 0.64 |
| Cash EPS (Rs.) | 1.08 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.73 | 0.00 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.73 | 0.00 |
| Revenue From Operations / Share (Rs.) | 8.99 | 0.00 |
| PBDIT / Share (Rs.) | 1.16 | 0.00 |
| PBIT / Share (Rs.) | 0.40 | 0.00 |
| PBT / Share (Rs.) | 0.38 | 0.00 |
| Net Profit / Share (Rs.) | 0.32 | 0.00 |
| NP After MI And SOA / Share (Rs.) | 0.32 | 0.00 |
| PBDIT Margin (%) | 12.92 | 13.88 |
| PBIT Margin (%) | 4.52 | 6.18 |
| PBT Margin (%) | 4.29 | 6.01 |
| Net Profit Margin (%) | 3.58 | 6.05 |
| NP After MI And SOA Margin (%) | 3.58 | 6.05 |
| Return on Networth / Equity (%) | 0.77 | 0.00 |
| Return on Capital Employeed (%) | 0.96 | 0.00 |
| Return On Assets (%) | 0.74 | 0.00 |
| Current Ratio (X) | 7.78 | 0.00 |
| Quick Ratio (X) | 3.05 | 0.00 |
| Interest Coverage Ratio (X) | 54.94 | 36.83 |
| Interest Coverage Ratio (Post Tax) (X) | 16.23 | 37.05 |
| Enterprise Value (Cr.) | 14.65 | 0.00 |
| EV / Net Operating Revenue (X) | 1.74 | 0.00 |
| EV / EBITDA (X) | 13.47 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.90 | 0.00 |
| Price / BV (X) | 0.40 | 0.00 |
| Price / Net Operating Revenue (X) | 1.90 | 0.00 |
| EarningsYield | 0.01 | 0.00 |
After reviewing the key financial ratios for Tainwala Chemicals & Plastics (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 14, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 13) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 14, the value is 0.32. This value is below the healthy minimum of 5. It has decreased from 0.64 (Mar 13) to 0.32, marking a decrease of 0.32.
- For Diluted EPS (Rs.), as of Mar 14, the value is 0.32. This value is below the healthy minimum of 5. It has decreased from 0.64 (Mar 13) to 0.32, marking a decrease of 0.32.
- For Cash EPS (Rs.), as of Mar 14, the value is 1.08. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 13) to 1.08, marking an increase of 1.08.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 14, the value is 41.73. It has increased from 0.00 (Mar 13) to 41.73, marking an increase of 41.73.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 14, the value is 41.73. It has increased from 0.00 (Mar 13) to 41.73, marking an increase of 41.73.
- For Revenue From Operations / Share (Rs.), as of Mar 14, the value is 8.99. It has increased from 0.00 (Mar 13) to 8.99, marking an increase of 8.99.
- For PBDIT / Share (Rs.), as of Mar 14, the value is 1.16. This value is below the healthy minimum of 2. It has increased from 0.00 (Mar 13) to 1.16, marking an increase of 1.16.
- For PBIT / Share (Rs.), as of Mar 14, the value is 0.40. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 0.40, marking an increase of 0.40.
- For PBT / Share (Rs.), as of Mar 14, the value is 0.38. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 0.38, marking an increase of 0.38.
- For Net Profit / Share (Rs.), as of Mar 14, the value is 0.32. This value is below the healthy minimum of 2. It has increased from 0.00 (Mar 13) to 0.32, marking an increase of 0.32.
- For NP After MI And SOA / Share (Rs.), as of Mar 14, the value is 0.32. This value is below the healthy minimum of 2. It has increased from 0.00 (Mar 13) to 0.32, marking an increase of 0.32.
- For PBDIT Margin (%), as of Mar 14, the value is 12.92. This value is within the healthy range. It has decreased from 13.88 (Mar 13) to 12.92, marking a decrease of 0.96.
- For PBIT Margin (%), as of Mar 14, the value is 4.52. This value is below the healthy minimum of 10. It has decreased from 6.18 (Mar 13) to 4.52, marking a decrease of 1.66.
- For PBT Margin (%), as of Mar 14, the value is 4.29. This value is below the healthy minimum of 10. It has decreased from 6.01 (Mar 13) to 4.29, marking a decrease of 1.72.
- For Net Profit Margin (%), as of Mar 14, the value is 3.58. This value is below the healthy minimum of 5. It has decreased from 6.05 (Mar 13) to 3.58, marking a decrease of 2.47.
- For NP After MI And SOA Margin (%), as of Mar 14, the value is 3.58. This value is below the healthy minimum of 8. It has decreased from 6.05 (Mar 13) to 3.58, marking a decrease of 2.47.
- For Return on Networth / Equity (%), as of Mar 14, the value is 0.77. This value is below the healthy minimum of 15. It has increased from 0.00 (Mar 13) to 0.77, marking an increase of 0.77.
- For Return on Capital Employeed (%), as of Mar 14, the value is 0.96. This value is below the healthy minimum of 10. It has increased from 0.00 (Mar 13) to 0.96, marking an increase of 0.96.
- For Return On Assets (%), as of Mar 14, the value is 0.74. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 13) to 0.74, marking an increase of 0.74.
- For Current Ratio (X), as of Mar 14, the value is 7.78. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 13) to 7.78, marking an increase of 7.78.
- For Quick Ratio (X), as of Mar 14, the value is 3.05. This value exceeds the healthy maximum of 2. It has increased from 0.00 (Mar 13) to 3.05, marking an increase of 3.05.
- For Interest Coverage Ratio (X), as of Mar 14, the value is 54.94. This value is within the healthy range. It has increased from 36.83 (Mar 13) to 54.94, marking an increase of 18.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 14, the value is 16.23. This value is within the healthy range. It has decreased from 37.05 (Mar 13) to 16.23, marking a decrease of 20.82.
- For Enterprise Value (Cr.), as of Mar 14, the value is 14.65. It has increased from 0.00 (Mar 13) to 14.65, marking an increase of 14.65.
- For EV / Net Operating Revenue (X), as of Mar 14, the value is 1.74. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 1.74, marking an increase of 1.74.
- For EV / EBITDA (X), as of Mar 14, the value is 13.47. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 13.47, marking an increase of 13.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 14, the value is 1.90. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 1.90, marking an increase of 1.90.
- For Price / BV (X), as of Mar 14, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 13) to 0.40, marking an increase of 0.40.
- For Price / Net Operating Revenue (X), as of Mar 14, the value is 1.90. This value is within the healthy range. It has increased from 0.00 (Mar 13) to 1.90, marking an increase of 1.90.
- For EarningsYield, as of Mar 14, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 13) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Tainwala Chemicals & Plastics (India) Ltd:
- Net Profit Margin: 3.58%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.96% (Industry Average ROCE: 14.04%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.77% (Industry Average ROE: 11.51%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 16.23
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.05
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.1 (Industry average Stock P/E: 19.39)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.58%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Sheets/Films | Tainwala House, Road No. 18, Mumbai Maharashtra 400093 | cs@tainwala.in http://www.tainwala.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Tainwala | Chairman & Managing Director |
| Ms. Upasana Babel | Director - Finance & CFO |
| Mr. Rakesh Tainwala | Non Executive Director |
| Mr. Uday Ramniklal Mehta | Independent Director |
| Mr. Devendra Saligram Anand | Independent Director |
| Mr. Ketan Dhirajlal Barai | Independent Director |
FAQ
What is the intrinsic value of Tainwala Chemicals & Plastics (India) Ltd?
Tainwala Chemicals & Plastics (India) Ltd's intrinsic value (as of 11 December 2025) is 99.79 which is 36.84% lower the current market price of 158.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 149 Cr. market cap, FY2025-2026 high/low of 320/158, reserves of ₹162.66 Cr, and liabilities of 188.43 Cr.
What is the Market Cap of Tainwala Chemicals & Plastics (India) Ltd?
The Market Cap of Tainwala Chemicals & Plastics (India) Ltd is 149 Cr..
What is the current Stock Price of Tainwala Chemicals & Plastics (India) Ltd as on 11 December 2025?
The current stock price of Tainwala Chemicals & Plastics (India) Ltd as on 11 December 2025 is 158.
What is the High / Low of Tainwala Chemicals & Plastics (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Tainwala Chemicals & Plastics (India) Ltd stocks is 320/158.
What is the Stock P/E of Tainwala Chemicals & Plastics (India) Ltd?
The Stock P/E of Tainwala Chemicals & Plastics (India) Ltd is 20.1.
What is the Book Value of Tainwala Chemicals & Plastics (India) Ltd?
The Book Value of Tainwala Chemicals & Plastics (India) Ltd is 184.
What is the Dividend Yield of Tainwala Chemicals & Plastics (India) Ltd?
The Dividend Yield of Tainwala Chemicals & Plastics (India) Ltd is 1.90 %.
What is the ROCE of Tainwala Chemicals & Plastics (India) Ltd?
The ROCE of Tainwala Chemicals & Plastics (India) Ltd is 4.24 %.
What is the ROE of Tainwala Chemicals & Plastics (India) Ltd?
The ROE of Tainwala Chemicals & Plastics (India) Ltd is 3.31 %.
What is the Face Value of Tainwala Chemicals & Plastics (India) Ltd?
The Face Value of Tainwala Chemicals & Plastics (India) Ltd is 10.0.